Wilex AG | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR0.46 |
Market Cap |
EUR76.58 M |
Shares Outstanding |
28.16 M |
Public Float |
5.89 M |
Address |
Schriesheimer Strasse 101 Ladenburg Baden Wuerttemberg 68526 Germany |
Employees | - |
Website | http://heidelberg-pharma.com |
Updated | 07/08/2019 |
Heidelberg Pharma AG engages in the development of diagnostic and therapeutic products for the detection and targeted treatment of various types of cancer. It operates through the following segments: Customer Specific Research (Cx), Diagnostics (Dx), andTherapeutics (Rx). The Customer Specific Research segment includes preclinical and Antibody Drug Conjugate technology services. |